description

Sanofi and Regeneron Pharmaceuticals said they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Reuters reports the new list price for Praluent will be $5,850 a year, matching the price Amgen set when it lowered the list of its competing drug, Repatha, in October. Sanofi and Regeneron said they expect the lower-priced Praluent to be available for pharmacies to order in early March.

general info

  • Uploaded    02/11/2019
  • News & Politics
  • Democrat Buttigieg Aims To Save Millions Of Lives Through Mental Healt...
  • فشل عملية التحام مركبة روسية تحمل إنسا...
  • محامي البشير يقول إنه سيطلب إطلاق سراح...
  • Вышел первый трейлер нового сериала п...
  • Biden asks: What if Obama 'had been assassinated?'
  • في أحدث رد انتقامي.. ترامب يرفع الرسوم ...
  • В Москве стартовал фестиваль военных ...
  • Blinded under IS rule Iraqi teen realises radio dream
  • Russian spacecraft carrying robot fails to dock with space station